Subscribe for the newsletter
Sign in
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Juniper Pharmaceuticals
Sort By
Newest First
1 / 1
Failed to load
Acquisition
Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.
Catalent
PR-M09-18-NI-028
Sep 11, 2018
1 / 1
